Oncology PracticeNeoadjuvant, adjuvant, or both? The debate in NSCLC rages onOctober 27, 2023Lung CancerPatient & Survivor Care
Oncology PracticePerioperative nivolumab improves EFS in resectable NSCLCOctober 22, 2023Lung CancerPatient & Survivor Care
Oncology PracticeNeoadjuvant advantages: Treating locally advanced lung cancerOctober 18, 2023Lung Cancer
Oncology PracticeThis is how you get patients back for follow-up cancer testingOctober 10, 2023Breast CancerPreventive CareLung Cancer
Oncology PracticeHigher RT doses can boost lifespan, reduce risk of death in LS-SCLC patientsOctober 5, 2023Lung CancerPatient & Survivor Care
Oncology PracticeReducing cognitive impairment from SCLC brain metastasesOctober 4, 2023Patient & Survivor CareLung Cancer
Oncology PracticeThese adverse events linked to improved cancer prognosisSeptember 28, 2023ImmunotherapyMelanomaLung CancerMixed Topics
Oncology PracticeTherapeutic vaccine shows promise in treating lung cancerSeptember 20, 2023Lung Cancer
Oncology PracticeNew ‘C word’: Cure should be the goal for patients with lung cancerSeptember 20, 2023Lung Cancer
Oncology PracticeMany patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?September 18, 2023Lung Cancer
Oncology PracticeNivolumab/Ipillimumab combo demonstrates long-term efficacy in NSCLCSeptember 18, 2023Lung CancerPractice Management
Oncology PracticeProposed TNM update could shift staging for lung cancersSeptember 14, 2023Lung Cancer
